BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Pancreas
,
Alcohol
,
Fluoxetine
,
rs4950928
,
VEGFA
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
fbxo32 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Primary mammary epithelial cells with EMT-inducer TGFb and with FBXO32 or CTBP1 siRNA knockdowns
Explore Curated Studies Results
Literature
Most Relevant Literature
The atypical ubiquitin ligase RNF31 stabilizes c-Myc via epigenetic inactivation of FBXO32 and promo…
DNMT1-mediated regulating on FBXO32 promotes the progression of glioma cells through the regulation …
FBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression.
Downregulation of BASP1 Promotes Temozolomide Resistance in Gliomas via Epigenetic Activation of the…
Advanced glycation end products impair coronary artery BK channels via AMPK/Akt/FBXO32 signaling pat…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effects of Protein Hydrolysate Supplementation Influencing Strength Recovery and Expression of Muscl…
Impact of Muscle Temperature on Muscle Growth and Breakdown: Cooling During Resistance Training
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ